ProShares Ultra Nasdaq Biotechnology
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.95
資產淨值: 85.11
成立日期: 06/04/2010
 
分析
市值分佈:
53.76%
大市值
6.31%
中市值
2.60%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 248  
0%
 
100%
     10大 (31.38%)
代號 名稱 佔比% 持有日期
GILDGilead Sciences6.4827/02/2026
VRTXVertex Pharmaceuticals6.2727/02/2026
AMGNAmgen6.1527/02/2026
REGNRegeneron Pharmaceuticals4.0627/02/2026
SGEN3.4130/11/2023
AZNAstraZeneca PLC2.8331/12/2025
ALNYAlnylam Pharmaceuticals2.2127/02/2026
INSMInsmed Incorporated1.6027/02/2026
BIIBBiogen1.4227/02/2026
ARGXargenx SE1.1227/02/2026
MRNAModerna1.0527/02/2026
ROIVRoivant Sciences Ltd1.0127/02/2026
INCYIncyte Corp1.0027/02/2026
RPRXRoyalty Pharma plc0.9927/02/2026
RVMDRevolution Medicines0.9927/02/2026
ASNDAscendis Pharma A/S0.7227/02/2026
NBIXNeurocrine Biosciences0.6627/02/2026
IONSIonis Pharmaceuticals0.6627/02/2026
SNYSanofi ADS0.6527/02/2026
BBIOBridgeBio Pharma0.6427/02/2026
 1    2    3    4    5    6    7    8    9    10    11    12    13  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.